Medpace Holdings, Inc.MEDPNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.29% | +7.66% | +9.30% | +14.24% | +23.74% |
| Gross Profit Growth | +26.89% | +30.34% | +14.96% | +17.01% | +16.53% |
| EBITDA Growth | +30.51% | +37.72% | +8.46% | +4.65% | +25.12% |
| Operating Income Growth | +32.23% | +43.58% | +9.08% | +20.15% | +26.31% |
| Net Income Growth | +36.68% | +49.45% | +11.70% | +2.16% | +15.25% |
| EPS Growth | +35.22% | +48.24% | +13.55% | +10.88% | +27.01% |
| EPS Diluted Growth | +35.59% | +49.19% | +14.69% | +12.73% | +28.57% |
| Weighted Average Shares Growth | +1.36% | +0.74% | -1.48% | -4.84% | -6.49% |
| Weighted Average Shares Diluted Growth | +1.03% | +0.59% | -2.52% | -5.99% | -7.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +30.33% | +21.91% | -17.58% | +27.60% | +65.16% |
| Free Cash Flow Growth | +31.09% | +25.01% | -21.29% | +37.56% | +89.35% |
| Receivables Growth | +6.38% | -0.66% | +6.82% | +25.51% | +19.77% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +40.18% | +26.80% | +5.66% | -18.14% | -15.88% |
| Book Value per Share Growth | +84.66% | +46.62% | -10.28% | -76.28% | -64.38% |
| Debt Growth | -10.32% | -11.18% | -6.97% | +13.68% | +12.24% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +18.86% | +6.87% | +31.34% | +12.57% | -2.31% |